JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core MSCI EAFE ETF
IEFA
|
+$2.04B |
| 2 |
iShares MSCI EAFE ETF
EFA
|
+$1.31B |
| 3 |
Apple
AAPL
|
+$746M |
| 4 |
Trane Technologies
TT
|
+$676M |
| 5 |
AABA
Altaba Inc
AABA
|
+$658M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P Mid-Cap ETF
IJH
|
+$2.16B |
| 2 |
Honeywell
HON
|
+$701M |
| 3 |
iShares Russell Mid-Cap ETF
IWR
|
+$667M |
| 4 |
Vanguard Morningstar Mid-Cap ETF
VO
|
+$656M |
| 5 |
General Motors
GM
|
+$586M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 22.9% |
| 2 | Financials | 14.86% |
| 3 | Technology | 11.73% |
| 4 | Healthcare | 9.66% |
| 5 | Consumer Discretionary | 8.64% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
351
Henry Schein
HSIC
$9.46B
| $241M | 0.06% |
3,359,801
-505,645
| -13% | -$35.2M |
2013 Q2
16 quarters
|
|
352
Alexandria Real Estate Equities
ARE
$8.15B
| $241M | 0.06% |
1,997,637
+255,378
| +15% | +$29.7M |
2013 Q2
16 quarters
|
|
353
TechnipFMC
FTI
$27B
| $240M | 0.05% |
11,859,050
-2,632,607
| -18% | -$59.4M |
2013 Q2
16 quarters
|
|
354
Teva Pharmaceutical Industries Limited
TEVA
$46.1B
| $239M | 0.05% |
7,207,699
-575,544
| -7% | -$17.8M |
2013 Q2
16 quarters
|
|
|
SPLK
355
DELISTED
Splunk Inc
SPLK
| $239M | 0.05% |
4,203,468
-444,367
| -10% | -$27.6M |
2013 Q2
16 quarters
|
|
356
Lincoln National
LNC
$7.72B
| $239M | 0.05% |
3,537,245
+857,436
| +32% | +$56.7M |
2013 Q2
16 quarters
|
|
357
PUT
Baidu
BIDU
$28.7B
| $239M | 0.05% |
1,335,600
+939,600
| +237% | +$170M |
2015 Q2
8 quarters
|
|
358
Elevance Health
ELV
$83.8B
| $239M | 0.05% |
1,269,249
+811,537
| +177% | +$146M |
2013 Q2
16 quarters
|
|
359
Crown Holdings
CCK
$11.5B
| $237M | 0.05% |
3,979,074
-868,570
| -18% | -$49M |
2013 Q2
16 quarters
|
|
360
Cinemark Holdings
CNK
$4.18B
| $237M | 0.05% |
6,095,192
+160,113
| +3% | +$6.63M |
2013 Q2
16 quarters
|
|
361
Rockwell Automation
ROK
$50.5B
| $236M | 0.05% |
1,459,185
+81,416
| +6% | +$12.8M |
2013 Q2
16 quarters
|
|
362
National Health Investors
NHI
$3.23B
| $236M | 0.05% |
2,976,456
-17,735
| -0.6% | -$1.34M |
2014 Q4
10 quarters
|
|
363
AptarGroup
ATR
$7.62B
| $235M | 0.05% |
2,707,778
+23,666
| +0.9% | +$1.95M |
2013 Q2
16 quarters
|
|
364
National Fuel Gas
NFG
$7.26B
| $235M | 0.05% |
4,204,469
+222,965
| +6% | +$12.6M |
2013 Q2
16 quarters
|
|
365
State Street SPDR S&P Biotech ETF
XBI
$10.5B
| $234M | 0.05% |
3,032,849
-346,845
| -10% | -$24.6M |
2013 Q2
16 quarters
|
|
366
Ametek
AME
$57.8B
| $233M | 0.05% |
3,849,425
-635,018
| -14% | -$37.4M |
2013 Q2
16 quarters
|
|
367
Edgewell Personal Care
EPC
$1.24B
| $232M | 0.05% |
3,057,051
+140,952
| +5% | +$10.4M |
2013 Q2
16 quarters
|
|
368
Pool Corp
POOL
$5.87B
| $231M | 0.05% |
1,967,101
-23,950
| -1% | -$2.88M |
2013 Q2
16 quarters
|
|
369
Tyson Foods
TSN
$18.3B
| $230M | 0.05% |
3,665,093
-2,190,401
| -37% | -$134M |
2013 Q2
16 quarters
|
|
370
Incyte
INCY
$23.4B
| $229M | 0.05% |
1,821,947
+111,252
| +7% | +$14.2M |
2013 Q2
16 quarters
|
|
371
Xtrackers MSCI Japan Hedged Equity ETF
DBJP
$738M
| $228M | 0.05% |
5,861,163
-58,060
| -1% | -$2.23M |
2013 Q3
15 quarters
|
|
372
Hubbell
HUBB
$25.1B
| $227M | 0.05% |
2,001,863
-2,296
| -0.1% | -$266K |
2015 Q4
6 quarters
|
|
373
Yum China
YUMC
$13.5B
| $224M | 0.05% |
5,683,406
-847,405
| -13% | -$30.6M |
2016 Q4
2 quarters
|
|
|
BBBY
374
DELISTED
Bed Bath & Beyond Inc
BBBY
| $221M | 0.05% |
7,279,286
-184,939
| -2% | -$6.68M |
2013 Q2
16 quarters
|
|
375
Realty Income
O
$51.2B
| $221M | 0.05% |
4,127,028
-1,342,562
| -25% | -$74.3M |
2013 Q2
16 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2017 Portfolio in Review
As of Q2 2017, JP Morgan Chase held 5,542 positions worth $438B, down 0.01% from $438B the previous quarter. Its ten largest holdings account for 18% of the portfolio.
JP Morgan Chase's Q2 2017 filing shows 462 new, 1,879 increased, 2,145 reduced and 563 closed positions. Its largest new stake was Altaba Inc: 12,081,650 shares worth $658M. The largest sale was iShares Core S&P Mid-Cap ETF, an estimated $2.16B.
By sector, the portfolio is most concentrated in Miscellaneous at 23% of assets, down from 24% a quarter earlier, followed by Financials and Technology.
- JP Morgan Chase's largest Q2 2017 buy was Altaba Inc: 12,081,650 shares worth $658M.
- JP Morgan Chase added most to iShares Core MSCI EAFE ETF in Q2 2017, an estimated $2.04B increase.
- JP Morgan Chase's biggest Q2 2017 reduction was iShares Core S&P Mid-Cap ETF, cutting an estimated $2.16B.
- JP Morgan Chase fully exited Energy Transfer Partners L.p. in Q2 2017, selling an estimated $439M.
- JP Morgan Chase's ten largest holdings make up 18% of its $438B portfolio in Q2 2017.
- JP Morgan Chase opened 462 new positions and closed 563 in Q2 2017.
- JP Morgan Chase's portfolio value fell 0.01% quarter-over-quarter to $438B.
Based on JP Morgan Chase's 13F filing for Q2 2017, filed 9 Aug 2017.